Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer.
Garrido-Laguna, I
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer. [electronic resource] - British journal of cancer Aug 2010 - 649-55 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1532-1827
10.1038/sj.bjc.6605819 doi
Adenocarcinoma--drug therapy
Adult
Aged
Antibiotics, Antineoplastic--therapeutic use
Female
Gene Expression Profiling
Humans
Intracellular Signaling Peptides and Proteins--antagonists & inhibitors
Male
Middle Aged
Pancreatic Neoplasms--drug therapy
Protein Serine-Threonine Kinases--antagonists & inhibitors
Signal Transduction
Sirolimus--therapeutic use
TOR Serine-Threonine Kinases
Xenograft Model Antitumor Assays
Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer. [electronic resource] - British journal of cancer Aug 2010 - 649-55 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1532-1827
10.1038/sj.bjc.6605819 doi
Adenocarcinoma--drug therapy
Adult
Aged
Antibiotics, Antineoplastic--therapeutic use
Female
Gene Expression Profiling
Humans
Intracellular Signaling Peptides and Proteins--antagonists & inhibitors
Male
Middle Aged
Pancreatic Neoplasms--drug therapy
Protein Serine-Threonine Kinases--antagonists & inhibitors
Signal Transduction
Sirolimus--therapeutic use
TOR Serine-Threonine Kinases
Xenograft Model Antitumor Assays